{"organizations": [], "uuid": "74305f44cadfbd76f67ba23a50872a34618dc705", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180309.html", "section_title": "Archive News &amp; Video for Friday, 09 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/idUSL5N1QR200", "country": "US", "domain_rank": 408, "title": "BRIEF-OncoArendi Therapeutics Plans IPO In March/April", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.085, "site_type": "news", "published": "2018-03-09T18:03:00.000+02:00", "replies_count": 0, "uuid": "74305f44cadfbd76f67ba23a50872a34618dc705"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/idUSL5N1QR200", "ord_in_thread": 0, "title": "BRIEF-OncoArendi Therapeutics Plans IPO In March/April", "locations": [], "entities": {"persons": [{"name": "oncoarendi", "sentiment": "negative"}], "locations": [{"name": "wa", "sentiment": "none"}, {"name": "warsaw", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "trigon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 9 (Reuters) - ONCOARENDI THERAPEUTICS SA ( IPO-ORT.WA ):\n* PLANS INITIAL PUBLIC OFFERING IN MARCH/APRIL * UNDER OFFER COMPANY WILL ISSUE NO LESS THAN 500,000 AND NO MORE THAN 2 MILLION NEW SHARES\n* INTENDS TO ALLOCATE ABOUT 90% OF OFFERED SHARES TO INSTITUTIONAL INVESTORS AND ABOUT 10% TO RETAIL INVESTORS\n* TRIGON DOM MAKLERSKI IS INTERMEDIARY IN OFFER * COMPANY SPECIALIZES IN DEVELOPMENT AND COMMERCIALIZATION OF NEW DRUGS USED IN TREATMENT OF CANCERS AND RESPIRATORY DISEASES\n* INFORMED ABOUT PLANNED DEBUT ON WARSAW STOCK EXCHANGE IN DEC, 2017\nSource text: bit.ly/2HfVjfx\nFurther company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://bit.ly/2HfVjfx", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-09T18:03:00.000+02:00", "crawled": "2018-03-10T20:12:13.040+02:00", "highlightTitle": ""}